KODI BONE: Open Payments
NPI 1184886012 · LUDINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,327 in 99 payments from 39 companies in 2025. Trend: 2023 $2,346 · 2024 $2,106 · 2025 $2,327
Food & beverage: $2,327
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $192 |
| Incyte Corporation | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| AstraZeneca Pharmaceuticals LP | 4 | $112 |
| Genentech USA, Inc. | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Legend Biotech USA Inc. | 3 | $94 |
| Eisai Inc. | 3 | $91 |
| PFIZER INC. | 5 | $90 |
Products named: JAKAFI, KEYTRUDA, LIBTAYO, Enhertu, CARVYKTI, Lenvima, SCEMBLIX, Polivy.
Industry payments across MI — which companies pay providers there.
